Clinical Trials Directory

Trials / Conditions / Kidney

Kidney

14 registered clinical trials studyying Kidney — 2 currently recruiting.

StatusTrialSponsorPhase
Enrolling By InvitationClinical Trial to Evaluate the Effectiveness and Safety of a Remote Automated Ultrasound Diagnostic System for
NCT06487312
Tongji Hospital—
Enrolling By InvitationAE05ML Device for ML Hem-o-lok Polymer Clip Delivery in Laparoscopic Surgical Procedures Observational Registe
NCT06364865
Teleflex—
CompletedThe Effect of Pneumoperitoneum (Raised Pressure in the Peritoneal Cavity) During Robotic Kidney/Prostate Cance
NCT04755452
Aalborg University HospitalN/A
Active Not RecruitingA Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cel
NCT03634540
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)Phase 2
Active Not RecruitingPilot Study of an mHealth Intervention for Living Donor Follow-up
NCT03400085
Johns Hopkins UniversityN/A
CompletedPharmacokinetic Study of Adoport® (Tacrolimus) in Patients With de Novo Kidney Transplantation
NCT03076151
University Hospital, LimogesPhase 4
CompletedComparison of Two Techniques of Renal Pre-transplant Infusion on the Evolution of Renal Function in the Recipi
NCT02826213
University Hospital, Tours—
CompletedChronic Kidney Disease & Therapeutic Exercise
NCT03301987
Universidad de LeónN/A
Active Not RecruitingUse of Financial Incentives to Increase Live Kidney Donor Follow-up Compliance
NCT03090646
Johns Hopkins UniversityN/A
CompletedIntensive Insulin Therapy and Acute Kidney Injury. Analysis Using RIFLE Criteria.
NCT00738504
Hospital Sao Domingos—
CompletedNadroparin Anticoagulation for Continuous Venovenous Hemofiltration
NCT00965328
Onze Lieve Vrouwe GasthuisPhase 4
UnknownAssessment of Changes in Renal Cortical and Medullary Blood Flow by Contrast Ultrasound
NCT00631553
University of VirginiaN/A
UnknownImpact of Total Nephrectomy on Patients With Kidney Stone
NCT01235104
University of Sao Paulo General Hospital—
CompletedCombination Therapy With 5-Fluorouracil, Interferon-an Interleukin-2, & Thalidomide for Metastatic, Advanced o
NCT00277017
New Mexico Cancer Research AlliancePhase 1 / Phase 2